BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 12452070)

  • 21. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
    Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
    Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship of carbohydrate antigen 19-9 and Lewis antigens in pancreatic cancer.
    Tempero MA; Uchida E; Takasaki H; Burnett DA; Steplewski Z; Pour PM
    Cancer Res; 1987 Oct; 47(20):5501-3. PubMed ID: 3308077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
    Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E
    Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative tissue carcinoembryonic antigen (T CEA) assay as a screening test for severe dysplasia in colorectal adenomas.
    Rosandić M; Skegro M; Paar V; Paar D; Sćukanec-Spoljar M; Juricić M; Vucelić B; Pulanić R; Rustemović N; Ostojić R; Ljubojević N
    Acta Med Austriaca; 1999; 26(3):89-92. PubMed ID: 10520376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A sialoglycoprotein (LEA.135) associated with favourable prognosis of patients with lymph node-negative primary breast carcinoma.
    Imam SA; Chaiwun B; Wang MJ; Morris MM; Groshen SG; Neville AM; Torloni H; Cote RJ; Taylor CR
    Anticancer Res; 1996; 16(5B):3043-8. PubMed ID: 8920764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum and tissue CEA in colorectal cancer: clinical relevance.
    Moreno Carretero G; Cerdán Miguel FJ; Maestro de las Casas ML; Martínez Cortijo S; Ortega MD; Pardo Martínez M; Balibrea Cantero JL
    Rev Esp Enferm Dig; 1998 Jun; 90(6):391-401. PubMed ID: 9708004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor marker concentrations in normal and malignant tissues of colorectal cancer patients and their prognostic relevance.
    Gebauer G; Müller-Ruchholtz W
    Anticancer Res; 1997; 17(4A):2731-4. PubMed ID: 9252706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thomsen-Friedenreich antigen presents as a prognostic factor in colorectal carcinoma: A clinicopathologic study of 264 patients.
    Baldus SE; Zirbes TK; Hanisch FG; Kunze D; Shafizadeh ST; Nolden S; Mönig SP; Schneider PM; Karsten U; Thiele J; Hölscher AH; Dienes HP
    Cancer; 2000 Apr; 88(7):1536-43. PubMed ID: 10738210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carcinoembryonic antigen and CA19-9: implications of quantitative marker measurement in tissues for prognosis of colorectal cancer.
    Gebauer G; Müller-Ruchholtz W
    Cancer Detect Prev; 2001; 25(4):344-51. PubMed ID: 11531011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [CEA, CA 19.9 and CA 195 in patients with colorectal carcinoma. ROC analysis].
    Vallejo J; Torres-Avisbal M; Contreras P; Rodríguez-Liñán M; Rebollo A; González F; Benítez A; Infante J; Mateo A
    Rev Esp Med Nucl; 1999 Aug; 18(4):281-6. PubMed ID: 10481111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical detection of carcinoembryonic antigen in esophageal carcinomas: a comparison with other gastrointestinal neoplasms.
    Bhatnagar J; Heroman W; Murphy M; Austin GE
    Anticancer Res; 2002; 22(3):1849-57. PubMed ID: 12168881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
    Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
    Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A cell surface glycoprotein expressed by colorectal carcinomas including poorly differentiated, noncarcinoembryonic antigen-producing colorectal tumors.
    Salem RR; Wolf BC; Sears HF; Thomas P; Bollinger B; Zamcheck N; Saravis CA; Chen LB; Steele G
    Cancer Res; 1988 Dec; 48(24 Pt 1):7257-63. PubMed ID: 3056611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnostic application of detecting AgNOR in peripheral blood T lymphocyte in patients with esophageal carcinoma].
    Wang JY; Rong TH; Liang YR; Long H; Chen QL; Ma GW
    Ai Zheng; 2004 May; 23(5):577-80. PubMed ID: 15142458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of brain-type glycogen phosphorylase is a potentially novel early biomarker in the carcinogenesis of human colorectal carcinomas.
    Tashima S; Shimada S; Yamaguchi K; Tsuruta J; Ogawa M
    Am J Gastroenterol; 2000 Jan; 95(1):255-63. PubMed ID: 10638593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of phosphorylated Ser70 of Bcl-2 correlates with malignancy in human colorectal neoplasms.
    Kondo E; Miyake T; Shibata M; Kimura T; Iwagaki H; Nakamura S; Tanaka T; Ohara N; Ichimura K; Oka T; Yanai H; Shibasaki F; Yoshino T
    Clin Cancer Res; 2005 Oct; 11(20):7255-63. PubMed ID: 16243795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Significance of CEA and CA242 in the diagnosis of colorectal carcinoma].
    Wu J; Yu H; Shao Y
    Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):438-40. PubMed ID: 8697997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
    Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
    Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of carcinoembryonic antigen and nonspecific cross-reacting 50-kDa antigen in human normal and cancerous colon mucosa: comparative ultrastructural study with monoclonal antibodies.
    Baranov V; Yeung MM; Hammarström S
    Cancer Res; 1994 Jun; 54(12):3305-14. PubMed ID: 8205554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.